Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$132.51 - $164.9 $149,868 - $186,501
1,131 Added 18.05%
7,397 $996,000
Q1 2023

Apr 19, 2023

BUY
$144.61 - $166.54 $906,126 - $1.04 Million
6,266 New
6,266 $998,000
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $210,640 - $261,345
-1,596 Closed
0 $0
Q4 2021

Jan 19, 2022

BUY
$107.43 - $135.93 $171,458 - $216,944
1,596 New
1,596 $216,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wt Wealth Management Portfolio

Follow Wt Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wt Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Wt Wealth Management with notifications on news.